These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34976399)

  • 1. A case of effective intravenous methylprednisolone pulse therapy against severe COVID-19 infection after arteriovenous graft surgery.
    Kamata S; Hamanaka S; Tsukamoto J; Tsuchimoto T; Fujiwara K; Okamura M
    Respirol Case Rep; 2022 Jan; 10(1):e0889. PubMed ID: 34976399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparison of the Effects of Dexamethasone and Methylprednisolone, Used on Level-3 Intensive Care COVID-19 Patients, on Mortality: A Multi-Center Retrospective Study.
    Sari A; Ekinci O; Saraçoğlu KT; Balık R; Aslan M; Balık Y; Önal C; Aslan M; Cevher S; Parmaksız A; Vatansever Ş; Çicek MC; Ayan ÖS; Şensöz Çelik G; Toprak A; Yılmaz M; Yurt E; Bakan N; Tekin S; Adıyeke E
    J Korean Med Sci; 2023 Jul; 38(29):e232. PubMed ID: 37489719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pulse methylprednisolone on prognosis in SARS-CoV-2 patients with severe pneumonia.
    Eraslan BZ; Fidan A; Baysal T; Cömert SS; Kıral N; Parmaksız ET
    Eur Rev Med Pharmacol Sci; 2024 Feb; 28(3):1234-1240. PubMed ID: 38375729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial.
    Busani S; Tosi M; Mighali P; Vandelli P; D'Amico R; Marietta M; Forfori F; Donati A; Cinnella G; De Monte A; Pasero D; Bellani G; Tascini C; Foti G; Ranieri M; Girardis M
    Trials; 2020 Aug; 21(1):724. PubMed ID: 32807241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of methylprednisolone pulse vs conventional dexamethasone for adult cases of COVID-19 requiring oxygen; a Japanese retrospective cohort study.
    Watanabe Y; Nakamura I; Sato S; Fujita H; Kobayashi T; Watanabe H
    J Infect Chemother; 2023 Mar; 29(3):269-273. PubMed ID: 36436740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous methylprednisolone pulse therapy and the risk of in-hospital mortality among acute COVID-19 patients: Nationwide clinical cohort study.
    Moromizato T; Sakaniwa R; Tokuda Y; Taniguchi K; Shibuya K
    Crit Care; 2023 Feb; 27(1):53. PubMed ID: 36755340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pulse-dose and high-dose corticosteroids with no corticosteroid treatment for COVID-19 pneumonia in the intensive care unit.
    Yaqoob H; Greenberg D; Hwang F; Lee C; Vernik D; Manglani R; Wang Z; Murad MH; Chandy D; Epelbaum O
    J Med Virol; 2022 Jan; 94(1):349-356. PubMed ID: 34542192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia.
    Pinzón MA; Ortiz S; Holguín H; Betancur JF; Cardona Arango D; Laniado H; Arias Arias C; Muñoz B; Quiceno J; Jaramillo D; Ramirez Z
    PLoS One; 2021; 16(5):e0252057. PubMed ID: 34033648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence.
    Wagner C; Griesel M; Mikolajewska A; Metzendorf MI; Fischer AL; Stegemann M; Spagl M; Nair AA; Daniel J; Fichtner F; Skoetz N
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD014963. PubMed ID: 36385229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse Methylprednisolone Versus Dexamethasone in COVID-19: A Multicenter Cohort Study.
    Watanabe A; Inokuchi R; Kuno T; Uda K; Komiyama J; Adomi M; Ishisaka Y; Abe T; Tamiya N; Iwagami M
    Crit Care Explor; 2023 Apr; 5(4):e0886. PubMed ID: 36998527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Efficacy of High-Dose Pulse Therapy vs. Low-Dose Intravenous Methylprednisolone on Severe to Critical COVID-19 Clinical Outcomes: A Randomized Clinical Trial.
    Sahraei Z; Panahi P; Solhjoukhah K; Mesbah M; Afaghi S; Amirdosara M; Salamzadeh J; Esmaeili Tarki F; Alavi Darazam I
    Iran J Pharm Res; 2023; 22(1):e137838. PubMed ID: 38116548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulse corticosteroid therapy with methylprednisolone or dexamethasone.
    Hari P; Srivastava RN
    Indian J Pediatr; 1998; 65(4):557-60. PubMed ID: 10773904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous dexamethasone vs methylprednisolone pulse therapy in the treatment of acute endothelial graft rejection.
    Tandon R; Verma K; Chawla B; Sharma N; Titiyal JS; Kalaivani M; Vajpayee RB
    Eye (Lond); 2009 Mar; 23(3):635-9. PubMed ID: 18292787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Stage Combination Treatment with Methylprednisolone Pulse and Remdesivir for Severe COVID-19 Pneumonia.
    Mastruzzo C; Commodari E; Grasso U; La Rosa VL; Balsamo D; Circo C; Oliveri R
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36673839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic corticosteroids for the treatment of COVID-19.
    Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylprednisolone pulse therapy for critically ill patients with COVID-19: a cohort study.
    Choi KJ; Jung SK; Kim KC; Kim EJ
    Acute Crit Care; 2023 Feb; 38(1):57-67. PubMed ID: 36935535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report of a combination of remdesivir, intravenous methylprednisolone pulse, and tocilizumab for severe coronavirus disease: 20-case series at a single institution.
    Ichiyama T; Komatsu M; Wada Y; Hanaoka M
    Respir Investig; 2022 Jul; 60(4):604-606. PubMed ID: 35501265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of patients with COVID-19 who are optimal for methylprednisolone pulse therapy.
    Ro S; Nishimura N; Imai R; Tomishima Y; So C; Murakami M; Okafuji K; Kitamura A; Jinta T; Tamura T
    Multidiscip Respir Med; 2021 Jan; 16(1):781. PubMed ID: 34322232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.